MITOZYTREX (MITOMYCIN) — FDA Approval NDA050763 (SUPERGEN)
MITOZYTREX (MITOMYCIN) — FDA Approval NDA050763 (SUPERGEN) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: MITOZYTREX; Active ingredients: MITOMYCIN; Application number: NDA050763.
| Brand name | MITOZYTREX |
|---|---|
| Active ingredients | MITOMYCIN |
| Application number | NDA050763 |
| Sponsor | SUPERGEN |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20021114 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →